Saudi Arabia’s leading tertiary and quaternary hospital, King Faisal Specialist Hospital & Research Centre (KFSH&RC), has been at the forefront of the Kingdom’s advancements towards addressing the evolving healthcare needs in the region and globally. In recognition of its efforts, KFSH&RC has been ranked as the most valuable healthcare brand, placing 33 overall in the annual report on the most valuable and strongest Middle Eastern brands; concurrently, KFSH&RC placed 11th in the top 50 most valuable and strongest overall brands in Saudi Arabia by Brand Finance, the world’s leading valuation consultancy.
KFSH&RC stood out in the two studies because of its award-winning patient care capabilities, accomplished clinicians and researchers, world-class medical treatments, and state-of-the-art facilities under its centers of excellence specializing in Organ Transplantation, Pediatric Hematology, Oncology, Cardiology, Neurological Science, and Medical Genetics. In addition, the hospital was scored highly based on its significant investments in leading-edge infrastructures, frameworks and solutions to boost capabilities for improved patient outcomes.
Another one of KFSH&RC's notable investments is its milestone project, the Jeddah Mega Expansion Project. The project seeks to expand the hospital's operations by constructing a new building on approximately 2,000,000 square meters of land that could accommodate 1681 medical spaces and increase medical capacities, such as cardiovascular surgeries, by up to three times its current levels.
"We are honored to be recognized by Brand Finance, yet again, following our ranking in its Global Top 250 Hospitals 2023 report in which KFSH&RC was the highest-ranked Academic Medical Centre (AMC) in the Middle East and North Africa region and 20th in the global ranking. KFSH&RC's ranking in Brand Finance's regional and Saudi Arabian rankings testify to our steadfast commitment to supporting Saudi Vision 2030's Healthcare Transformation goals and driving world-class healthcare in the Kingdom and internationally. Moreover, these achievements are truly owed to the incredible efforts of our clinical, research, and education experts who work tirelessly towards uncovering and sustaining the best healthcare outcomes for all," said Muhannad A. Kadi, Chief Corporate Communications Officer at KFSH&RC.
“King Faisal Specialist Hospital and Research Centre (KFSH&RC) entered the ranking for the first time. Its in-house capabilities, expertise, and world-class facilities have allowed the hospital to build a strong brand perception amongst patients within the Middle East as one of the premier choices for healthcare. This was first demonstrated in Brand Finance's Global Top 250 Hospitals 2023 report, wherein KFSH&RC's patient-centric focus, strong regional reputation for integrated educational and research capabilities, contributed to a high score in patient treatment," commented Andrew Campbell, Brand Finance Managing Director, Middle East.